Kondo Wealth Advisors Inc. boosted its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 5.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,324 shares of the company’s stock after buying an additional 65 shares during the quarter. Kondo Wealth Advisors Inc.’s holdings in Procter & Gamble were worth $226,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of PG. Nova Wealth Management Inc. acquired a new stake in shares of Procter & Gamble in the 1st quarter valued at approximately $26,000. Capital A Wealth Management LLC bought a new position in Procter & Gamble in the 4th quarter valued at approximately $31,000. Quarry LP bought a new position in Procter & Gamble in the 1st quarter valued at approximately $33,000. 10Elms LLP acquired a new stake in Procter & Gamble in the fourth quarter valued at approximately $34,000. Finally, Mizuho Securities Co. Ltd. grew its stake in shares of Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after buying an additional 170 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Jennifer L. Davis sold 8,596 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,351,892.92. Following the transaction, the chief executive officer directly owned 64,991 shares of the company’s stock, valued at approximately $10,221,134.57. The trade was a 11.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sundar G. Raman sold 9,554 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the sale, the chief executive officer directly owned 41,886 shares of the company’s stock, valued at approximately $6,624,689.76. This trade represents a 18.57% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 120,181 shares of company stock valued at $18,918,012 in the last 90 days. Company insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the prior year, the firm posted $1.40 earnings per share. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 64.82%.
Analyst Ratings Changes
PG has been the topic of several recent research reports. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an “equal weight” rating in a report on Thursday, July 31st. UBS Group set a $180.00 price target on Procter & Gamble and gave the company a “buy” rating in a research note on Wednesday, July 30th. BNP Paribas restated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Finally, Evercore ISI reiterated an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $175.12.
Check Out Our Latest Stock Analysis on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- How to invest in marijuana stocks in 7 steps
- High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
- How to Use the MarketBeat Dividend Calculator
- Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
- What is an Earnings Surprise?
- Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.